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Abstract
Accumulation of unconjugated bilirubin (UCB) in the brain causes bilirubin encephalopathy. Pgp (ABCb1) and Mrp1 (ABCc1),
highly expressed in the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) respectively, may modulate
the accumulation of UCB in brain. We examined the effect of prolonged exposure to elevated concentrations of UCB on
expression of the two transporters in homozygous, jaundiced (jj) Gunn rats compared to heterozygous, not jaundiced (Jj)
littermates at different developmental stages (2, 9, 17 and 60 days after birth). BBB Pgp protein expression was low in both jj
and Jj pups at 9 days (about 16–27% of adult values), despite the up-regulation in jj animals (2 and 1.3 fold higher than age
matched Jj animals at P9 and P17–P60, respectively); Mrp1 protein expression was barely detectable. Conversely, at the
BCSFB Mrp1 protein expression was rather high (60–70% of the adult values) in both jj and Jj at P2, but was markedly (50%)
down-regulated in jj pups starting at P9, particularly in the 4
th ventricle choroid plexuses: Pgp was almost undetectable. The
Mrp1 protein down regulation was accompanied by a modest up-regulation of mRNA, suggesting a translational rather
than a transcriptional inhibition. In vitro exposure of choroid plexus epithelial cells obtained from normal rats to UCB, also
resulted in a down-regulation of Mrp1 protein. These data suggest that down-regulation of Mrp1 protein at the BSCFB,
resulting from a direct effect of UCB on epithelial cells, may impact the Mrp1-mediated neuroprotective functions of the
blood-cerebrospinal fluid barrier and actually potentiate UCB neurotoxicity.
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Introduction
Severe jaundice from unconjugated bilirubin (UCB) can occur
transiently in newborn infants with immature hepatic conjugating
capacity [1,2,3,4,5] and lifelong in patients with Crigler-Najjar
type I disease [6,7]. Over 99.9% of UCB in blood is bound to
plasma proteins (primarily albumin) that do not enter the brain
[8,9,10]. Only the small fraction of unbound bilirubin may diffuse
into the brain and cerebrospinal fluid (CSF). With severe jaundice,
the serum binding sites approach saturation and unbound UCB
(free bilirubin, Bf) will rise dramatically even at lower biliruibin/
albumin molar ratios [2,11]. Under these conditions, the
accumulation of UCB in brain (kernicterus) can produce toxicity
and result in permanent brain injury.
The exchange of unbound UCB between the blood and the brain
may be modulated by two blood-brain interfaces that control
cerebral homeostasis [12]. Directly contacting the neuroglia, the
blood-brain barrier consists of tightly bound, specialized endothelial
cellslining thebrain microvessels[13].Asecond interface,the blood-
cerebrospinal fluid barrier is provided by the epithelial cells of the
choroid plexuses, and controls exchanges between plasma and CSF.
Both barriers display a large surface area for exchanges [14]. Tight
junctions [15,16] preclude the paracellular passage of hydrophilic
compounds [17], while transporters [18] and metabolizing enzymes
[19,20,21,22] control the neural access of lipid-soluble substrates.
Two trans-membrane proteins, belonging to the ATP binding
cassette (ABC) family, have been identified as potential UCB
transporters, which export the pigment from the cells. MDR1
(ABCb1: Pgp, Mdr1a/1b in rodents) displays a low affinity for
UCB [23] and MRP1 (ABCc1: Mrp1 in rodents) that possess a
very high affinity for UCB (Km for Bf=10 nM) [24]. In rat as well
as in human brain, Pgp is specifically expressed in microvessels,
localized at the luminal (blood) side of the endothelium, while
Mrp1 is mostly localized at the basolateral membrane of the
choroidal epithelium, facing the stromal/blood space. Pgp protein
increases during post-natal development, whereas Mrp1 is highly
expressed in choroid plexuses, even at birth [14,18,25,26]. Both
ABC transporters may participate in limiting the entry of UCB by
increasing its export from the central nervous system [27,28].
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gated hyperbilirubinemia on the developmental protein expression
of Mrp1 in the lateral and 4
th ventricle choroid plexuses, and of
Pgp in brain microvessels. We used immature and adult Gunn rats
[29], a well established animal model for chronic unconjugated
hyperbilirubinemia and kernicterus [30]. Homozygous, recessive
(jj) Gunn rats, like patients with Crigler-Najjar syndrome type I
(CNS I), develop severe, lifelong, non-hemolytic, unconjugated
hyperbilirubinemia, due to the congenital absence of UDP-
glucuronosyl transferase (UDPGT: EC 2.4.1.17) 1A1, the enzyme
that synthesizes excretable conjugates of UCB. The same enzyme
has transient low activity in jaundiced human newborns [31,32].
Heterozygous Jj animals, used as controls, have only a minimally




Gunn rats (Hds Blue:Gunn-UDPGTj) [29], originally purchased
from Harlan (Harlan, IL, USA) in 2006, were maintained in the
animal facility of the University of Trieste. Animal care and
procedureswereconductedaccordingtotheguidelines approved by
Italian Law (decree 116-92) and by European Community directive
86-609-EEC. Sacrifice was performed after anesthesia (isofluorane)
in order to avoid animal pain or stress, within the law 116-92.
Because animals spontaneously develop the pathology, and no
treatments have been applied, additional ethical approval was not
required. All efforts were made to avoid suffering of animals.
Littermates were obtained by breeding Jj females with jj males.
Parturitions were synchronized to obtain a sufficient number of
littermate pups of each genotype and post-natal age (P624 hrs). Jj
pups from the same litter were used as controls for jj animals. Post-
natal ages to study were selected based on developmental vulnerability
to bilirubin neurotoxicity established by others [34,35,36,37,38]. The
number of rats pooled for each batch and the number of batches
analyzed for each transporter are listed in Table 1.
Plasma bilirubin determination
A heparinized sample of blood was obtained by jugular
puncture from each anesthetized animal. After centrifugation
(1500 g for 20 min at room temperature), plasma was collected
under dim light to minimize bilirubin photo-oxidation and
immediately frozen at 220uC until assayed. The diazo-reaction
[39] (Boehringer-Mannheim Kit 1552414, Monza, Italy) was used
to quantify total plasma bilirubin. Hemolyzed samples were
discarded. More than 12 animals were used at every post-natal age
for each genotype.
Tissue dissection and preparation
Animals were euthanized under isofluorane anesthesia by decap-
itation (within the law 116-92). Two lateral ventricle choroid plexuses,
one from each hemisphere, 4
th ventricle choroid plexuses, cerebral
cortices and cerebella were dissected individually from four P2, P9,
P17 and P60 animals of each phenotype (see Table 1) in Krebs-Ringer
buffer (in mM: 135 NaCl, 4 KCl, 2.2 CaCl2,1 . 2M g C l 2,6N a H C O 3,
10 HEPES, 5 glucose, pH 7.4), at 4uC under stereomicroscope vision.
Spleens from Jj and jj animals were also dissected for Mrp1 analysis.
Brain microvessels were obtained as described previously [18]. Briefly,
pooled cerebral cortices were cleaned from all apparent meninges
under a stereomicroscope. For mature animals (P60), tissues were
homogenized in a Dounce-type glass-glass homogenizer after the
addition of 5 vol/g tissue of 1% bovine serum albumin-supplemented
Krebs-Ringer. The microvessels were separated from larger vessels
and brain parenchyma material by filtering through decreasing pore
diameter mesh sieves and the myelin was removed by centrifugation
on a 17.5% 70 KDa-Dextran gradient in Krebs-Ringer buffer at
3000 g for 30 min. The microvessel fraction retained on the 40 mm
sieve was recovered in 0.1% albumin in Krebbs-Ringer buffer,
centrifuged, and suspended in a small volume of the same buffer.
Because of the fragility of brain tissue, cerebral cortices of P17 animals
were homogenized by eight loose-type pestle strokes, while five loose-
type pestle strokes were used for P9 pups. Preparations contaminated
with larger vessels or tissue remnants were discarded. All steps were
performed at 4uC within 4 hours of decapitation. Samples were stored
at 280uCu n t i lu s ef o rW e s t e r nb l o t .
Sample preparation and Western blot quantification
Freshlyisolatedmicrovessels,and lateral and 4
thventriclechoroid
plexuses were homogenized in buffer (0.25 M Sucrose; 50 mM K
Phosphate; 1 mM EDTA; 0.1 mM DTT; pH 7.4), using a Dounce-
type glass-glass homogenizer. Total protein content was determined
using bicinchoninic acid (BCA), following the manufacturer’s
protocol (Procedure # TPRO 562, Sigma, St Louis, MO, USA).
Proteins were separated on 10% SDS-polyacrylamide gels.
Before transfer, the gel was cut longitudinally; the lower part
(containing the actins) was blotted on PVDF membrane (0.2 mm;
BioRad Laboratories, Hercules, CA, USA) at 100 V in transfer
buffer (25 mM Tris-Base; 192 M glycine, 0.1% SDS; 20%
methanol) for 1h, while the upper part of the gel (Mrp1 and
Pgp) was blotted for 2 hr, to achieve maximal transfer.
Completeness of transfer was assessed by lack of Coomassie blue
coloration of the gels after blotting.
PVDF membranes were saturated in blocking solution (4% non
fat milk in 20 mM Tris base; 500 mM NaCl, pH 7.4, supple-
mented with 0.2% Tween 20) for 1 hr, incubated overnight at 4uC
with antibodies against either Mrp1 (A23, produced in our
laboratory and commercialized by Alexis, Lausanne, Switzerland)
[40], Pgp (Abcam PLC, Cambridge, UK), or actin (Sigma; St
Louis, MO, USA). Antibodies were added at a final concentration
of 1.0, 4.8 and 1.2 mg/mL, respectively. Membranes were then
incubated for 2 hr with horseradish peroxidase-conjugated
secondary antibodies (both anti-mouse and anti-rabbit at 0.8 mg/
mL; Sigma; St Louis, MO, USA) in blocking solution. Specificity
of the antibodies against the two ABC transporters in rats was
previously confirmed [18], and checked again in this work (Fig. 1).
Horseradish peroxidase activity was developed using a chemi-
luminescence procedure (Millipore, Billerica, MA, USA), accord-
ing to the manufacturer’s protocol, and visualized on X-ray films
(BioMax Light, Kodak Rochester, NY, USA). The optical density
profile of each band revealed on the X-ray film was quantified by
ImageQuant software (GE Healthcare Europe GmbH, France).
Table 1. Animals and batches of samples used for the ABC
transporter analysis.
Post-natal age P2 P9 P17 P60 P120
MVs Animals* N.P. 8 6 4 N.P.
Batches N.P. 3 4 5 N.P.
CPs Animals*4 4 3 4 3
Batches 44 4 4 3
MVs: microvessels; CPs: choroid plexuses;
*: Animals pooled together to generate one batch. N.P.: not performed.
doi:10.1371/journal.pone.0016165.t001
UCB Induced Mrp1/Pgp Modulation at the BBI
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e16165Reference controls to quantify the relative contents of Pgp and
Mrp1 were obtained by serial dilutions of pooled microvessels and
4
th ventricle choroid plexuses obtained from P60 Jj Gunn rats and
run for each Western blot procedure (Fig. 1). A standard curve was
generated by non-linear regression (MMF model, each r.0.99) of
plots of optical density values versus the amount of reference sample
protein. Relative expression of the ABC transporters, normalized
for the actin signal, was calculated by CurveExpert 1.38 software
(Hixon, TN, USA). The results are expressed as mean 6 S.D., n=3
to 5 sample batches for each post-natal age (see Table 1).
Immunohistochemical detection of Mrp1 in rat brain
sections
Several rat brains of each genotype and developmental stage
were immediately snap-frozen after decapitation, and 10 mm-thick
slices were cryo-sectioned, using a Micron HM550 cryostat (Bio-
Optica, Milan, Italy). Sections were fixed at room temperature in
4% paraformaldehyde in phosphate buffer (PBS; in mM: NaCl
150; Na2HPO4 12; KH2PO4 2; pH 7.4) for 10 min, then blocked
for 1 hr in 5% BSA, 5% Normal Goat Serum, 0.3% Triton in
PBS. After overnight incubation at 4uC with the anti-Mrp1
antibody (final concentration 1 mg/mL) in blocking solution,
secondary anti-rabbit Alexa-conjugated antibodies (MolecularP-
robes, Carlsbad, CA, USA, 2 mg/mL, in 0.3% Triton-PBS) were
added and incubated for 2 hr at room temperature.
Nuclei were stained with Hoechst 33521 (0.1 mg/mL) in PBS for
10 min at room temperature and sections were mounted with
cytomation fluorescence mounting medium (S3023, Dako, Glostrup,
Denmark). Negative controls were performed by omitting the first
antibody. Fluorescent immunoreactions were observed using a Leica
DM200 fluorescence microscope, equipped with the Digital Camera
Leica DFC490 and the software Leica LAS Image Overlay (Leica,
Ernst-Leitz-Strasse 17–37, Wetzlar, D-35578, Germany).
Real Time-PCR analysis of Mrp1 mRNA levels in choroid
plexuses of P9 animals
Lateral and 4
th ventricle choroid plexuses of Jj and jj Gunn rats
were collected in TriReagent (Sigma-Aldrich, St Louis, MO, USA).
Total RNA was isolated according to the manufacturer’s instructions.
Briefly,tissueswerelysedwiththereagent,chloroformwasaddedand
cellular RNA was precipitated by isopropyl alcohol. After washing
with 75% ethanol, the RNA pellet was dissolved in nuclease-free
water and stored at 280uC until further analysis. RNA was
quantified spectrophotometrically at 260 nm, and the RNA purity
was evaluated by measuring the ratio A260/A280, considering RNAs
with appropriate purity those showing values between 1.8 and 2.0.
RNA integrity was evaluated by gel electrophoresis.
Total RNA (1 mg) in 15 ml of nuclease-free water was added to
4 mL reaction mix, and 1 mL reverse transcriptase using the
iScript
TMcDNA Synthesis kit (Bio-Rad Laboratories, Hercules,
CA, USA) according to the manufacturer’s instructions. The
reaction was performed for 5 min at 25uC (annealing), 30 min at
42uC (cDNA synthesis), and 5 min at 85uC (enzyme denaturation).
Three house-keeping genes (beta-actin, 18S and GAPDH), each
corresponding to a different function in the cell, were employed to
normalize the results. The PCR reaction was performed on 25 ng
cDNA with gene-specific sense and anti-sense primers for Mrp1, b-
actin, GAPDH (all Mrp1; b-actin and GAPDH 250 nM) and 18S
(100 nM) (Table 2) with iQ SYBR Green Supermix (Bio-Rad
Laboratories, Hercules, CA, USA) in an i-Cycler IQ thermocycler
(Bio-Rad Laboratories, Hercules, CA, USA). The thermal cycler
conditions consisted of 3 min at 95u and 40 cycles each at 95uCf o r
20 s, 60uC for 20 s and 72uC for 30 s. Specificity of the amplification
was verified by a melting-curve analysis, performed immediately after
the amplification protocol, under the following conditions: 1 min
denaturation at 95uC, 1 min annealing at 55uC, and 80 cycles of
0.5uC increments (10 s each) beginning at 55uC. Non-specific
products of PCR were not found in any case. A standard curve
was generated using a ‘‘calibrator’’ cDNA (chosen among the cDNA
samples), which was serially diluted and analyzed for all genes to
determine the amplification efficiencies of individual genes. The
relative quantification was made using Genex software (Bio-Rad
Laboratories, Hercules, CA, USA) based on DDCt method, taking
into account the efficiencies of individual genes and normalizing the
results to the three house-keeping genes. The levels of Mrp1 mRNA
were expressed relative to a selected 4
th ventricle choroid plexuses Jj
reference sample. The results are expressed as mean 6 S.D., n=3
pools of choroid plexuses dissected from 4 animals.
Effect of bilirubin on Mrp1 protein in an in vitro model of
the blood-CSF barrier
Choroid plexus epithelial cells were isolated and cultured on Costar
Transwell Clear inserts (0.4 mm pore size, 6.5 mm diameter) as
Figure 1. Representative Western blot for Pgp, Mrp1 and Actin on Gunn preparations. Pgp expression was analyzed on microvessels
(MVs) preparations (A, upper panel). Mrp1 was quantified in lateral and 4
th ventricle (LV and 4
thV) choroid plexuses (B, upper panel). Actin staining
(both A and B, lower panel) was used to normalize the amount of samples loaded. For the quantification procedure, see the material and methods
section.
doi:10.1371/journal.pone.0016165.g001
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compartment of the bicameral system and exposed for 6 consecutive
days to daily renewed 7.5 mMo r2 0mM UCB, starting on day 4 after
plating. UCB was dissolved in DMSO (0.16 and 0.4% final volume, for
low and high dose, respectively) and diluted in culture medium
supplemented with 11.5% fetal bovine serum containing 30 mM
albumin. UCB concentration was adjusted to yield bilirubin/albumin
ratios calculated to have free bilirubin concentrations of approximately
40 and 140 nM [43]. Control monolayers were treated in parallel with
the same concentration of DMSO. On day 10, filters were cut and
transferred into 16 Lysis Buffer (Cell Signalling Technology, Saint-
Quentin Yvelines, France) and kept at 280uC, until processed for
W e s t e r nb l o ta n a l y s i so fb o t hM r p 1a n da c t i na sp r e v i o u s l yd e s c r i b e di n
detail [18]. Duplicate monolayers were included for each condition.
Actin was used to assess protein load of each sample.
Statistical analysis
Data are reported as mean 6 SD. Statistical differences between
hyperbilirubinemic animals and controls (Jj) were analyzed using
paired Student’s t-test for Western blot ABC transporter quantifi-
cation. Anova following by a Tukey-Kramer test was used to assess
variation in total plasma bilirubin concentration over time. One
tailed Student’s test for unequal variances was applied to assess
differences in cerebellar growth and plasma bilirubin concentration
and in mRNA levels between Jj and jj animals. Differences were
considered statistically significant at a p value lower than 0.05.
Results
Plasma bilirubin and cerebellar growth
A transient postnatal increase in total plasma bilirubin concentration
w a so b s e r v e di nJ ja n i m a l s ,d e c r e a s i n gt ot h el o wa d u l tv a l u e sb yP 1 7
(Fig. 2A). The total bilirubin in plasma of jj rats was significantly higher
(p,0.005) than in Jj rats at all post-natal ages and reached the peak
level (250 mM) at P9. A hallmark of bilirubin toxicity in jj rats is
cerebellar hypoplasia [37,44,45]. Cerebellar weights in jj and Jj animals
were identical at P2, but cerebellar growth was impaired thereafter in jj
animals and almost completely arrested by P17 (Fig. 2B). Thus, the jj
cerebellar weight was 25% lower at P9 (p,0.01), 40% lower at P17
(p,0.005) and 50% lower at P60 (p,0.005) than in Jj animals.
Characterization of isolated microvessels and choroid
plexus tissues
It was technically impossible to obtain microvessel preparations of
adequate purity from rat brain tissue at ages earlier than 9 days [18].
On phase contrast microscopic examination, microvessels preparations
consisted mostly of long, branched capillaries, with the thin structure of
the microvessels better appreciated at higher magnifications (Fig. 3, B–
Table 2. Primers used for transcript analysis, amplicon length and amplification efficiency.
Gene
Accession
Number Sense Antisense Amplicon Lenght (bp) Efficency (%)
Mrp1 NM_022281 ATGGTGTCAGTGGTTTAGG TGTGGGAAGAAGAGTTGC 111 99.2
B-Actin NM_031144 ATCGGCAATGAGCGGTTCC AGCACTGTGTTGGCATAGAGG 149 81.5
GAPDH NM_017008 CCATCACCATCTTCCAGGAG CCTGCTTCACCACCTTCTTG 576 88.1
18S X01117 TAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 150 74.7
doi:10.1371/journal.pone.0016165.t002
Figure 2. Plasma bilirubin and cerebellar weight in jj and Jj Gunn rats. The values are expressed as mean 6 SD of 12–20 animals for each
age and genotype. Round filled dots: jj animals; empty triangles: Jj controls. Panel A: total plasma bilirubin (Tbil) amount in developing
hyperbilirubinemic (jj) and control (Jj) Gunn rats. Tbil concentration differences between jj and age-matched Jj animals were all statistically significant
(P#0.005). Within each phenotype: **: p,0.005 vs. P60; 1 and 11 :p ,0.05 and 0.005 respectively vs. next age group. Panel B shows the cerebellar
growth expressed as g/animal. The level of significance is indicated by comparison with age-matched not jaundiced Jj animals.
doi:10.1371/journal.pone.0016165.g002
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observed (Fig. 3, B), and red blood cells were rarely found. Despite a
softer consistency of the cortices dissected from jaundiced jj rats,
vascular morphology was similar to Jj rats and no cellular alteration
(granulations, bubbles, etc.) was detected (Fig. 3, panel D, F for Jj and
panel C, E, G for jj). Similarly, no difference was noted in the
dimensions or morphology of either lateral or 4
th ventricle choroid
plexuses dissected from jaundiced or control Gunn rats.
Pgp protein expression in microvessels
In agreement with previous data on rats and mice, Pgp
expression in microvessels strongly increased from the early post
Figure 3. Blood brain barrier localization in rat brain, and microvessels isolated from rats. Cartoon representation of the lateral, 3
rd,4
th
ventricle choroid plexuses (LV CP, 3
rd V CP and 4
thV CP, respectively) and microvessels (MVs) localization in rat brain (A). Representative microvessels
freshly isolated from rat brains. Freshly isolate MVs in 0.1% albumin in Krebbs-Ringer buffer were placed on a microscope slide and directly observed
by phase contrast microscopy: In B scale bar 100 mm; in C, D, E, F and G scale bar 25 mm. P: post-natal age in days. jj: hyperbilirubinemic rats; Jj:
controls.
doi:10.1371/journal.pone.0016165.g003
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higher in jj animals than in Jj littermates at every post-natal age
analyzed (Fig. 4). The maximal difference was observed at P9,
when the Pgp amount in jj was 1.8-fold the level expressed by Jj
age-matched controls (p,0.01). Differences were smaller at later
developmental ages (1.4-fold at P17, and 1.3-fold at P60), but
remained statistically significant (p,0.05). Notwithstanding bili-
rubin-induced up-regulation, the Pgp concentration in 9 day old jj
rats was still only 16% of the level found in mature Jj rats.
Mrp1 protein and mRNA expression in choroid plexuses
The expression of Mrp1 in the choroid plexuses was high at
birth, with values similar to adult levels (Fig 5, A and B). Mrp1
expression in jj and Jj rats were comparable at P2, but Mrp1
expression in jj animals fell to a nadir at P9 and remained
statistically lower than in Jj animals at later ages. At P60, the Mrp1
level of the jj rats was 50% lower in the 4
th ventricle choroid
plexuses (p,0.001) and 30% lower in the lateral ventricle choroid
plexuses (p,0.05) (Fig 5, B and A, respectively), than in Jj animals.
To assess the specificity of the decrease in Mrp1 found in CPs,
we analyzed the expression of this transporter in the spleen, an
organ that highly expresses Mrp1. In contrast to choroid plexuses,
Mrp1 expression in the spleen did not differ between jj and Jj rats
at any age (P9: 100.862.6 vs. 101.862.5; P17: 101.269.0 vs.
90.468.1, Jj vs. jj animals). When Mrp1 mRNA was analyzed by
real time PCR in P9 choroid plexus preparations, the expression
was comparable between Jj and jj rats, despite a 50% drop in
Mrp1 protein (Fig. 6).
The absence of either molecular weight shift or lower molecular
weight bands for Pgp in micro vessels and Mrp1 in choroid
plexuses in jj preparations suggests that hyperbilirubinemia does
not alter the post-translational maturation nor produce degrada-
tion of these transporters. In both JJ and jj Gunn rats, Pgp
expression in choroid plexuses and Mrp1 expression in microves-
sels were barely detectable (data not shown) as previously shown in
Sprague-Dawley rats [18].
Immunofluorescence analysis of Mrp1 cellular
localization in rat brain
Mrp1 was localized at the basolateral membrane of choroid
plexus epithelial cells, in both Jj and jj Gunn rat brain slices, even
at P2 (Fig. 7, A, D and E), in agreement with previous studies in
Sprague-Dawley rats [18]. No cytoplasmic staining was detected in
jj rats (compare D with E, and F with G), suggesting that UCB is
unable to reallocate the transporter in vivo. When the nuclei were
counterstained by Hoechst 33422, no apoptotic bodies were
detected, in keeping with the absence of macroscopic cellular
damage due to UCB.
Effect of UCB on Mrp1 protein expression in cultured
choroidal epithelium
Monolayers of choroidal epithelial cells were cultured in
bicameral devices, reconstituting in vitro the barrier properties of
the blood-CSF interface. Cells were exposed to 2 different
concentrations of unbound bilirubin (40 and 140 nM, which
mimic levels measured in physiological and pathological jaundice,
respectively) at the basolateral membrane site for 6 consecutive
days to mimic the in vivo prolonged postnatal exposure. This
treatment resulted in a decrease in Mrp1 protein at the higher
bilirubin concentration (Fig. 8). This effect was not accompanied
by any alteration in the paracellular permeability of the
monolayers to sucrose (data not shown), and therefore does not
reflect a pleiotropic toxicity. These data are in agreement with our
in vivo results and suggest that the reduction of Mrp1 protein
observed in jj animals in the blood-CSF barrier results from a
direct action of UCB on barrier cells.
Discussion
UCB can enter brain parenchyma either directly via the blood-
brain barrier, or by transfer across the choroid plexuses. The ABC
transporters, Pgp and Mrp1, have been proposed to modulate
brain entry of UCB [14]. In vitro, Pgp, mainly expressed in
microvessels, is a UCB transporter weaker than Mrp1 [23,24], the
latter being dominant in the choroid plexuses [18]. The effects of
prolonged exposure to high UCB levels in vivo as seen in severely
jaundiced newborns or Crigler-Najjar type I patients, on the post
natal-expression of Pgp and Mrp1 at the blood-brain interfaces
have not been reported.
We observed an up-regulation of Pgp protein in microvessels,
and a down-regulation of Mrp1 in choroid plexuses isolated from
hyperbilirubinemic jj Gunn rat pups as compared with their non-
jaundiced Jj littermate controls. Mechanisms mediating these
opposite responses are still uncertain. UCB has been show to affect
the cellular redox [48,49,50,51] state and Pgp expression is
increased by oxidative stress [52,53], suggesting that oxidative
Figure 4. Pgp relative expression in isolated Jj and jj Gunn rat
microvessels. The Pgp amount in each sample is expressed as % of
the Pgp amount in the Reference Sample (Pooled P60 Jj MVs
preparations). White bars: heterozygous (Jj) rats, black bars: hyperbilir-
ubinemic homozygous (jj) animals. The values are expressed as mean 6
SD. Statistical significance is indicated.
doi:10.1371/journal.pone.0016165.g004
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blood-brain barrier.
UDPGT activity is present in rat choroid plexuses [19,54] and
glucuronosyl conjugates are one of the substrates for Mrp1. In jj
Gunn rats, UGT1A1 activity is completely abolished by a genetic
mutation, suggesting that the resulting limited availability of Mrp1
substrates might lead to an Mrp1 down regulation in jj animals.
However, the normal protein expression of Mrp1 in choroid
plexuses of P2 pups (Fig 5) and in spleen and in liver (data not
shown) indicates that the Mrp1 protein reduction is not due to the
decrease in UGT activity but rather to a direct effect of the
prolonged exposure to high levels of UCB. This is further
supported by the in vitro data showing that UCB is per se able to
reduce the protein content of Mrp1 in choroid plexuses.
The lack of apparent degradation products of Mrp1 (Fig. 1,
Western blot), the normal localization at the basolateral mem-
brane (Fig. 7, immunofluorescence), together with the comparable
levels of mRNA in hyperbilirubinemic and control animals (Fig. 6)
suggest that the reduction in the content of Mrp1 protein observed
in jj rats occurs at the translational level. A similar effect, i.e.
reduced protein without changes in the mRNA level or
modifications in sub-cellular localization was observed for Mrp2
and Bile Salt Export Pump (BSEP; ABCB11) following lipopoly-
saccharide exposure in human liver [55,56].
Lipophilic compounds such as UCB cross cellular membranes
mainly by passive diffusion [17,57]. The protein up-regulation of
Pgp we observed is consistent with a defensive role proposed for
this transporter against bilirubin entry into brain. However,
despite this up-regulation, the expression of Pgp in response to the
elevated levels of UCB in jj Gunn rats in the first 2.5 weeks after
birth (P2–P17) remained very low compared to adult values (16
and 27% of adult Jj level, respectively). This suggests that Pgp
offers, at best, a marginal defense against bilirubin entry into brain
during the critical period (P2–P17) when the UCB-related
neurological damage occurs, as the diffuse yellow coloration of
the brains demonstrates (not shown). At the same time, the Mrp1
protein level in the choroid plexuses of jj animals is significantly
reduced, which may further impair the ability of the brain to
protect itself from UCB accumulation and toxicity. This has been
shown in vitro where silencing of Mrp1, but not Pgp, is associated
with a greater cellular toxicity induced by UCB exposure [58].
Figure 5. Mrp1 relative expression in the lateral and 4
th ventricle choroid plexuses dissected from Jj and jj Gunn rats. The Mrp1
protein amount present in each sample is expressed as % of the Mrp1 amount in the Reference Sample (pooled P60 Jj 4
thV CP preparations). White
bars: heterozygous (Jj) rats, black bars: hyperbilirubinemic homozygous (jj) animals. 4
thV CP: Forth Ventricle Choroid Plexuses; LV CP: Lateral Ventricles
Choroid Plexuses. Statistical significance is indicated.
doi:10.1371/journal.pone.0016165.g005
Figure 6. Comparison of Mrp1 mRNA and protein relative
expression in choroid plexuses. White bars: heterozygous (Jj) P9
rats, black bars: hyperbilirubinemic homozygous (jj) P9 animals. The
values are expressed as mean 6 SD. Statistical significance is reported.
NS: not significant difference.
doi:10.1371/journal.pone.0016165.g006
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development and is involved in regulating cerebral availability of
endogenous biologically active compounds (leukotriene [59],
steroid hormones [60], glutathione, glucuronide and sulfate
conjugates [61], reduced glutathione [62]) and therapeutic drugs
such as etoposide [63,64]. In line with the functional relevance of
these transport activities, the involvement of the transporter in
inflammation [65] and oxidative stress [66] has been demonstrat-
ed in vivo in Mrp1 KO mice.
We speculate that Mrp1 protein down-regulation observed in
jaundiced jj Gunn rat pups and maintained into adulthood, may
increase the central nervous system accumulation of toxins or
drugs, impair immune and endocrine response, and lead to
increased oxidative stress impairing neuronal development
independent of bilirubin itself. In summary, we provide evidence
that major alterations in Pgp and Mrp1 expression are induced in
the BBB and BCSFB, respectively, by prolonged exposure to
elevated levels of UCB, as seen in jj Gunn rats.
Although the mechanisms of these alterations in expression are
currently undetermined, we propose that the modulation of UCB
Figure 7. Immunofluorescence for Mrp1 on Gunn rat brain slices during post-natal development. A, B, D, F: heterozygous (Jj) animals. C,
E, G: hyperbilirubinemic homozygous (jj) animals. A negative control obtained omitting the first antibody is shown in B. A and C, show the specific
expression of Mrp1 at the blood-cerebrospinal fluid barrier of Jj and jj Gunn rats. Green: Mrp1;Blue: Nuclei; R : basolateral side; * : parenchyma. In D, E
(P2 Jj vs jj) and F,G (P9 Jj vs jj) magnifications showing Mrp1 localization at the basolateral side of choroidai plexus cells.
doi:10.1371/journal.pone.0016165.g007
Figure 8. Western blot analysis of Mrp1 protein in the
choroidal epithelium following bilirubin treatment. Duplicate
monolayers of choroidal epithelial cells were included for each
experimental condition. Following daily basolateral treatment with 40
or 140 nM unbound bilirubin for 6 consecutive days, filters were treated
in exactly the same conditions. The homogeneity in protein loading is
reflected by the actin band revealed on the lower part of the
membrane.
doi:10.1371/journal.pone.0016165.g008
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to bilirubin, possibly mediated in part by an alteration in the
cellular redox state.
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